Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: Bradykinin receptor agonists or antagonists

TheScientificWorldJournal

Volumn 6, Issue , 2006, Pages 1247-1261

  Sharma, J N ^a   Al Sherif, G J ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Bradykinin; Bradykinin agonists; Bradykinin antagonists; Cardioprotection; Inflammation; Kallikrein kinin system

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 3 BROMO 8 [2,6 DICHLORO 3 [N [4 (N,N DIMETHYLCARBAMOYL)CINNAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLIMIDAZO[1,2 A]PYRIDINE; 8 [2,6 DICHLORO 3 [N [4 (N METHYLCARBAMOYL)CINNAMAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYL 4 (2 PYRIDYLMETHOXY)QUINOLINE; 8 [2,6 DICHLORO 3 [N [4 (N METHYLCARBAMOYL)CINNAMAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLQUINOLINE; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE; [LEUCYL 8 ]DES ARGINYL 9 BRADYKININ; ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR AGONIST; BRADYZIDE; CP 2522; FR 184280; ICATIBANT; KALLIKREIN; KININOGEN; L 755807; LABRADIMIL; LYSYL[LEUCYL 8 ]DES ARGINYL 9 BRADYKININ; LYSYLLYSYLARGINYLPROLYL(4 HYDROXYPROLYL)GLYCYL 2 (2,3 DIHYDRO 1H INDEN 2 YL)GLYCYLSERYL 2 (2,3 DIHYDRO 1H INDEN 2 YL)GLYCYLOCTAHYDRO 1H INDOLE 2 CARBOXYLIC ACID; MARTINELLINE; PHOSPHONIUM DERIVATIVE; PS 020990; QUINOLINE DERIVATIVE; SSR 240612; UNCLASSIFIED DRUG; UNINDEXED DRUG; WIN 62318;

ALLERGY; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DIABETES MELLITUS; GASTROINTESTINAL DISEASE; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; INFLAMMATION; KALLIKREIN KININ SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PROTEIN DEGRADATION; RESPIRATORY TRACT DISEASE; SMOOTH MUSCLE CONTRACTION; VASODILATATION;

BRADYKININ; CARDIOVASCULAR DISEASES; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATION; KALLIKREIN-KININ SYSTEM; KININS; RECEPTORS, BRADYKININ; RENIN-ANGIOTENSIN SYSTEM;

EID: 33750828145     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2006.226     Document Type: Article

References (30)

1. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
2. Duncan, A.M. et al. (2000) Kinins in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R897-904.
3. Wolfrum, S., Dendorfer, A., and Dominiak, P. (1999) Identification of kallidin degrading enzymes in the isolated perfused rat heart. Jpn. J. Pharmacol. 79, 117-120.
4. Marceau, F. et al. (2001) Ligand mediated regulation of kinin receptors in the rabbit. Biol. Chem. 382, 131-133.
5. Smith, C.J. et al. (1996) Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase in heart failure. Circ. Res. 78, 58-64.
6. Agata, J. et al. (2000) Bradykinin B1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension 36, 364-370.
7. Parenti, A. et al. (2001) The bradykinin B1 receptor promotes angiogenesis by up regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J. 15, 1487-1489.
8. Shin, J. et al. (2002) Bradykinin-12-lipooxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. U. S. A. 99, 10150-10155.
9. Stadnicki, A. et al. (2005) Immunolocalization and expression of kinin B1R and B2R in human inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 289, 6361-6366.
10. Yusuf Ozturk. (2001) Kinin receptors and their antagonists as novel therapeutic agents. Curr. Pharm. Des. 7, 135-161.
11. Uknis, A.B. et al. (2001) Bradykinin receptor antagonist type 2 attenuate the inflammatory changes in peptidoglycan induced acute arthritis in the Lewis rat. Inflamm. Res. 50, 149-155.
12. 2 trasgenic knockout mice. Br. J. Pharmacol. 129, 1732-1738.
13. Walsh, D.A. and Fan, T.P. (1997) Bradykinin as growth factor. In The Handbook of Immunopharmacology. The Kinin System. Farmer, S.G., Ed. Academic Press. p. 301-314.
14. 2 receptor agonists in the treatment of cardiovascular disease. Expert Opin. Investig. Drugs 12, 759-770.
15. Batenburg, W.W. et al. (2004) Mediators of bradykinin induced vasorelaxation in human coronary microarteries. Hypertension 43, 488-492.
16. 2 receptor knockout mice. Hypertension 37, 967-973.
17. 2 receptor is required for full expression renal COX-2 and renin. Peptides 24, 1141-1147.
18. 2 receptor activation reduces renal fibrosis. Jelin Investig. 110, 371-379.
19. Bernstein, K.E. (2002) Two ACEs and a heart. J. Nat. 471, 799-802.
20. Dedio, J. et al. (2001) Tissue kallikrein KLK is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins. Biol. Chem. 382, 1483-1490.
21. Kikkawa, Y. et al. (1998) Prorenin processing and restricted endoproteolysis by mouse tissue kallikrein family enzymes (mk1, mk9, mk13, and mk22). Biochim. Biophys. Acta 1382, 55-64.
22. AbdAlla, S. et al. (2001) Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. J. Nat. Med. 7, 1003-1009.
23. Leeb-Lundberg, L.M. et al. (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77.
24. Ma, D. et al. (2001) First total synthesis of martinellic acid, a naturally occurring bradykinin receptor antagonist. J. Org. Lett. 3, 2189-2191.
25. Borlongan, C.V. and Emerich, D.F. (2003) Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidences from bradykinin receptor agonist, cereport. Brain Res. Bull. 60, 297-306.
26. Narotam, P.K. et al. (1998) Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127. J. Acta Neurochir. (Wien) 140, 793-802.
27. Christiansen, S.C. et al. (2002) Upregulation of functional kinin B1 receptors in allergic airway inflammation. J. Immunol. 169, 2054-2060.
28. Stewart, J.M. (2003) Bradykinin antagonist as anticancer agents. Curr. Pharm. Des. 9, 2036-2042.
29. Sharma, J.N. (2003) Does the kinin system mediate in cardiovascular abnormalities? An overview. J. Clin. Pharmacol. 43(11), 1187-1195.
30. Moreau, M.E. et al. (2005) The kallikrein-kinin system: current and future pharmacological targets. J. Pharmacol. Sci. 99, 15-16.